Prostanoid receptor agonists for glaucoma treatment
Research Rationale BPC-157 upregulates angiogenic growth factors (VEGF, TGF-) to build vascular infrastructure TB-500 provides the actin-binding platform for cell migration into the repair site BPC-157 modulates nitric oxide synthesis and protects endothelial integrity, while TB-500 regulates inflammatory signalling and reduces oxidative stress The two peptides target separate phases of tissue repair: BPC-157 drives early-stage angiogenesis and granulation, TB-500 supports later-stage matrix remodelling Each compound is individually vialled and batch-traceable with independent COAs stack at your chosen concentrations Research Applications This stack is used in laboratory models of soft tissue repair, wound healing assays, endothelial cell migration studies, and inflammation-modulation research
patients with chronic gut and inflammatory conditions
The treated ligaments could withstand forces approaching those of uninjured tissue, suggesting the peptide promotes functional rather than merely structural repair
Many of the adverse events attributed to peptides trace back to contaminated or mislabeled research-grade products, not the peptides themselves
Price point is fantastic for the benefits received
